Table 2.
Route of Administration | Onset of Action (min) | Peak Plasma Levels (min) | Bioavailability |
---|---|---|---|
Oral | 15–60 | 30–90 | 100% |
IM | 15–30 | 30–60 | 60% |
Rectal | 5–10 | 10–45 | 80–90% |
Intranasal | <5 | >60 | 97% |
Route of Administration | Onset of Action (min) | Peak Plasma Levels (min) | Bioavailability |
---|---|---|---|
Oral | 15–60 | 30–90 | 100% |
IM | 15–30 | 30–60 | 60% |
Rectal | 5–10 | 10–45 | 80–90% |
Intranasal | <5 | >60 | 97% |